Search

Author/Creator Yu, Lou

1. A randomized, double blind, dose escalation, first time in human study to assess the safety, tolerability, pharmacokinetics, and antiviral activity of single doses of GSK2485852 in chronically infected hepatitis C subjects. Issue 6 (20th October 2014)

Authors:
Wilfret, David A.; Walker, Jill; Voitenleitner, Christian; Baptiste‐Brown, Sharon; Lovern, Mark; Kim, Joseph; Adkison, Kimberly; Shotwell, Brad; Mathis, Amanda; Moss, Lee; Lee, Daniel; Yu, Lou; Gan, Jianjun; Spaltenstein, Andrew
Journal:
Clinical pharmacology in drug development
Issue:
Volume 3:Issue 6(2014:Nov./Dec.)
Page Start:
439
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Randomised controlled trial: susceptibility‐guided therapy versus empiric bismuth quadruple therapy for first‐line Helicobacter pylori treatment. Issue 11 (24th April 2019)

Authors:
Chen, Qi; Long, Xiaohua; Ji, Yingjie; Liang, Xiao; Li, Dongping; Gao, Hong; Xu, Beili; Liu, Ming; Chen, Ying; Sun, Yunwei; Zhao, Yan; Xu, Gang; Song, Yanyan; Yu, Lou; Zhang, Wei; Liu, Wenzhong; Graham, David Y.; Lu, Hong
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 49:Issue 11(2019)
Page Start:
1385
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗